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Abstract 
Background: Excessive apoptosis of airway epithelium is reported to induce airway remodeling and inhibited airway 
epithelium repair is highly associated with development of asthma and chronic obstructive pulmonary disease. Der 
p 2 is a major allergen derived from Dermatophagoides pteronyssinus and commonly causes airway hypersensitive‑
ness and asthma; however, the connection between Der p 2 and epithelial apoptosis remains unclear. This study was 
aimed to explore whether Der p 2 induces apoptosis of airway epithelial cells and the underlying mechanisms.
Results: Our results showed that recombinant Der p 2 (rDP2) inhibited cell growth and induced apoptosis of human 
bronchial epithelial cell BEAS‑2B. Further investigation revealed that rDP2 increased intracellular reactive oxygen spe‑
cies, level of cytosolic cytochrome c and cleavage of caspase‑9 and caspase‑3. rDP2 also induced activation of p38 
mitogen‑activated protein kinase (P38) and c‑Jun N‑terminal kinase (JNK), and triggered proapoptotic signals includ‑
ing decrease of Bcl‑2, increase of Bax and Bak, and upregulation of Fas and Fas ligand. In parallel, rDP2 inhibited glyco‑
gen synthase kinase 3beta and consequently enhanced degradation of cellular (FADD‑like IL‑1β‑converting enzyme)‑
inhibitory protein (c‑FLIP). Involvement of toll‑like receptor (TLR)2 in rDP2‑induced apoptosis was also demonstrated 
using specific small inhibitory RNA.
Conclusions: Our findings indicate that rDP2 suppresses cell growth and trigger apoptosis of BEAS‑2B cells, which 
may attribute to induction of both intrinsic and extrinsic pathway via TLR2 and P38/JNK signaling and c‑FLIP deg‑
radation. It suggests that Der p 2 may aggravate respiratory disorders through enhancement of apoptosis and the 
consequent airway injury.
© 2015 Lin et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Respiratory epithelium is a primary physical barrier 
which prevents invasion of pathogens and environmen-
tal factors such as allergens and air pollutants. In patients 
with chronic obstructive pulmonary disease and asthma, 
the epithelial barrier exhibits detachment of columnar 
ciliated cells, presence of epithelial cell aggregates in spu-
tum, increased permeability to allergens and disturbed 
expression of the junction molecule at sites of epithelial 
detachment [1]. These structural changes and functional 
disorders of airway epithelium are highly associated 
with increased cell apoptosis and enhanced interactions 
between the epithelial and immune and/or somatic cells 
underneath, which putatively induce airway remodeling 
and irreversible airway damages [2, 3]. In addition, it is 
evident that level of epithelial damage is correlated with 
degree of severity of airway hyperresponsiveness [4].
House dust mite (HDM) is one of the most important 
sources of indoor allergens and has been known as a pre-
dominant causative of respiratory disorders such as air-
way hypersensitiveness, asthma and exacerbation of lung 
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function. HDM derived major allergens are categorized 
into two groups, proteolytic group-1 and non-proteolytic 
group-2 on the basis of IgE affinity [5]. Recently, non-
proteolytic group-2 HDM allergens including Der p 2 
and Der f 2 have received increased interest in the role 
in activating immune response in asthma patients. Der 
p 2 has been demonstrated to share not only structural 
homology but also functional similarity with MD-2 pro-
tein that confers responsiveness to lipopolysaccharide in 
association with toll-like receptor (TLR) 4 [6]. It has also 
been reported that Der p 2 aggravates respiratory airway 
disorder by induction of inflammatory cytokines and up-
regulation of intercellular adhesion molecule-1 [7]. How-
ever, association between Der p 2 and epithelial apoptosis 
has been rarely explored.
Apoptosis of airway epithelial cells plays a pivotal role 
in pathogenesis of chronic respiratory disorders [8]. The 
increase in loss of epithelial integrity in the airway of 
asthmatics has been suggested as an imbalance between 
proliferation and apoptosis of epithelial cell, and the 
resultant decreased adhesion of the epithelial cells to the 
basement contributes to the epithelial layer shedding in 
airway [9]. Previous studies have also implicated modu-
lation of cell survival through apoptosis in the patho-
genesis of chronic airway diseases [10, 11]. Although 
apoptosis is postulated as a critical cellular process in the 
development and progression of chronic airway diseases, 
influences of aeroallergens on epithelial apoptosis and 
the underlying signaling cascades remain sketchy. In the 
present study, we aimed to investigate effects of Der p 2 
on airway epithelial cells with emphasis on apoptosis and 
the underlying mechanisms.
Methods
Expression and purification of recombinant Der p 2 (rDP2)
rDP2 was expressed in a pGEX-T vector with the N-ter-
minal glutathione S-transferase (GST) moiety followed 
by Der p 2 in E. coli and purified using glutathione 
chromatography (Sigma-Aldrich, St. Louis, MO, USA) 
according to manufacturer’s instructions. Control pro-
tein GST was expressed and purified as same as rDP2. 
After filtrated with 0.22-μm sterile filter (Millipore, Bed-
ford, MA), the purified proteins were quantitated using 
BCA protein assay kit (Pierce Biotechnology, Rockford, 
IL, USA) according to the manufacturer’s instructions 
and used for the following treatments.
Cell culture and treatments
Immortalized, nontumorigenic human bronchial epi-
thelial cell line BEAS-2B was obtained from ATCC 
(CRL-2503) and cultured in complete growth medium 
consisting of RPMI1640 supplemented with 10  % fetal 
bovine serum (FBS). Cells were maintained at 37 ℃ in a 
humidified atmosphere with 5  % CO2 and subcultured 
according to resources’ instructions.
For protein expression, cells at a density of 5  ×  105/
mL were incubated with rDP2 at serial concentrations 
for 24  h. For kinase signaling analysis, cells at a density 
of 1  ×  106/mL were incubated with rDP2 (20  μg/mL) 
for 30  min. Inhibition of p38 mitogen-activated protein 
kinase (P38) or c-Jun N-terminal kinase (JNK) was per-
formed by pretreating cells with 10  μM SB203580 or 
SP600125 (Sigma-Aldrich) for 30 min, respectively. Inhi-
bition of Akt activation was performed by pretreating 
cells with wortmannin at 200 nM for 30 min.
Cell viability assay
Cell viability was determined using 3-(4,5-cimethylthia-
zol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. 
Cells were seeded at a density of 4 × 104 cells/well in a 
24-well plate and cultured for 24 h. Then, the cells were 
treated with rDP2 at 5, 10, 20 and 40  μg/mL for 24  h. 
After the treatments, cells were washed with phosphate-
buffered saline (PBS), and then incubated with 5  mg/
mL MTT solution for 4  h. After removing the super-
natant, isopropanol was added to solubilize the result-
ing formazan. Absorbance at 563  nm was measured for 
cell viability. Three independent experiments were per-
formed for statistical analysis.
Cell cycle distribution analysis
Cells were seeded in 6-well plates at a density of 1 × 105 
cells and treated with varying concentrations of rDP2 (10, 
20, 40 μg/mL), GST (40 μg/mL) or vehicle for 24 h. After 
incubation, cells were trypsinized, washed twice with 
ice-cold PBS, and fixed overnight in 70 % ethanol at 4 ℃. 
Cells were then resuspended in PBS and treated with 
1 mg/mL of RNase A and 1 mg/mL of propidium iodide 
in PBS for 45 min. Cell-cycle distribution was evaluated 
using flow cytometer (FACS Calibur, version 2.0, BD 
Biosciences, Franklin Lakes, NJ, USA) using CellQuest 
software. Quantitative data were obtained from three 
independent experiments.
Detection of apoptotic cells
The apoptotic cells were detected and quantitated by 
using terminal deoxynucleotidyl transferase dUTP 
nick end labeling (TUNEL) system (Promega, Madi-
son, WI, USA) and propidium iodide (PI)/annexin V 
method (R&D Systems, Minneapolis, MN, USA) accord-
ing to the manufacturer’s instructions. For TUNEL sys-
tem, 4′,6-diamidino-2-phenylindole (DAPI) was used 
for nuclei staining. Signal detection was performed 
using a fluorescence microscopy (LSM 710, Carl-Zeiss, 
Oberkochen, Germany). The index of apoptosis was the 
average of the percentages of positive nuclei including 
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apoptotic bodies per total number of nuclei from five 
random observation fields at 200× magnitudes. For PI/
annexin V system, cells were washed with PBS and resus-
pended in medium containing GST (40 μg/mL) or rDP2 
(5 and 20 μg/mL). Cells staining with PI and binding fluo-
rescein isothiocyanate (FITC)-labeled annexin V were 
determined by flow cytometer (FACS Calibur, version 
2.0, BD Biosciences, Franklin Lakes, NJ, USA) using Cell-
Quest software. Quantitative data were obtained from 
three independent experiments.
Intracellular ROS determination
Production of intracellular reactive oxygen species (ROS) 
was determined by spectrofluorometrical method using 
2′,7′-dihydrodichlorofluorescein diacetate (DCFH-DA) 
assay with modification [24]. DCFH-DA diffuses through 
the cell membrane and is enzymatically hydrolyzed by 
intracellular esterases to the nonfluorescent DCFH, which 
can be rapidly oxidized to the highly fluorescent DCF, the 
fluorescent product, in the presence of ROS. After expo-
sure to GST or rDP2, DCFH-DA was added to the culture 
plates at a final concentration of 5 μM and incubated for 
40  min at 37 ℃ in darkness. DCF fluorescence intensity 
was detected with emission wavelength at 530  nm and 
excitation wavelength at 485 nm using a SpectraMax Plus 
microplate reader (Molecular Devices Corporation, Sun-
nyvale, CA, USA). The values were expressed as the mean 
absorbance normalized to the ratio of control value.
Subcellular fractionation
Cells were washed with PBS and incubated with lysis 
buffer (10  mM HEPES, pH 7.6; containing 15  mM KCl, 
2  mM MgCl2, 0.1  mM EDTA, 1  mM dithiothreitol, 
0.05 % Igepal CA-630 and 1 mM PMSF, 1 mM Na3VO4, 
50 mM NaF, 10 μg/mL leupeptin/aprotinin) for 10 min. 
Cell lysates were collected by a centrifugation at 2500 g 
for 10 min at 4 ℃. The supernatant containing the cyto-
sol was further centrifuged at 20,000g for 15 min at 4 ℃, 
namely cytosolic fraction. The pellets containing nuclei 
were washed with PBS, resuspended in nuclear buffer 
(25 mM HEPES, pH 7.6, 0.1 % Igepal CA-630, 1 M KCl, 
0.1  mM EDTA, 1  mM PMSF, 1  mM Na3VO4, 2  mM 
NaF, 10  μg/mL leupeptin/aprotinin), and centrifuged at 
10,000g for 15  min at 4 ℃. The resulting supernatants 
were collected, namely nuclear fraction.
Immunoblotting
Cells were collected and lysed for protein extraction and 
the followed immunoblotting as previously described 
[12]. Phosphorylation and level of protein was dem-
onstrated by using antibodies against human cellular 
proteins, including caspase-3, caspase-9, caspase-8, 
cytochrome c, Poly (ADP-ribose) polymerase (PARP), 
Bcl-2, Bak, Bax, Fas, FasL, phosphorylated P38 (p-P38), 
total P38, phosphorylated JNK (p-JNK), total JNK, phos-
phorylated glycogen synthase kinase 3beta (GSK3β) 
(Ser9), cellular FLICE inhibitory protein (c-FLIP), and 
α-tubulin (Cell signaling, Beverly, MA). Detection of 
antigen–antibody complex was performed by using ECL 
reagent (Millipore, Bedford, MA, USA) and lumines-
cence image system (LAS-4000 mini; Fujifilm, Tokyo, 
Japan). Semi-quantitation of reacted signals was deter-
mined using Multi Gauge software version 2.2 (FujiFilm, 
Tokyo, Japan). Three independent analyses were per-
formed for statistical analysis.
RNA extraction and quantitative real‑time PCR (qPCR)
Total RNA extraction was performed by using RNeasy 
mini kit (Qiagen, Hilden, Germany). cDNA was syn-
thesized from total RNA by reverse transcription using 
RevertAid First Strand cDNA Synthesis Kit (Thermo 
Fisher Scientific Inc, Waltham, MA). qPCR was per-
formed using the ABI PRISM 7700 sequence detection 
system (Applied Biosystems, Foster City, CA). For mRNA 
quantitation, FastStart Universal SYBR Green Master 
(Roche Applied Science, Mannheim, Germany) was used 
for Taqman PCR. Relative gene expressions were cal-
culated by using the 2−ΔΔCt method [2]. Expression of 
GADPH gene was used an internal endogenous control. 
All qPCR experiments were performed in duplicates for 
each sample. The correct size of the PCR products was 
confirmed by agarose gel electrophoresis.
Inhibition of TLR2 expression with small interfering RNA 
(siRNA)
To specifically inhibit TLR2 expression, a combination of 
three different siRNAs (3 target sequence for TLR2; UUC 
UCA UCU CAC AAA AUU G, CUU GUG ACC GCA 
AUG GUA U, and UCU UUA UGU CAC UAG UUA U) 
was used for transfection. Transfection was performed 
according to the manufacture’s instruction. Briefly, cells 
were seeded in a 96-well plate at 2 ×  104 cells/well and 
incubated at 37 ℃ and 5 % CO2 for 16 h. The siRNA solu-
tion was prepared in RNase-free buffered solution and 
the final concentration of each siRNA was 1 μM per well 
(Dharmacon® AccellTM siRNA reagents, Thermo scien-
tific, Hudson, NH, USA). After 72 h, the transfected cells 
were treated with rDP2 for 24 h.
Statistical analysis
Data were expressed as means ± SEMs of the three inde-
pendent experiments. Statistical significance analysis was 
determined by using 1-way ANOVA followed by Dun-
nett for multiple comparisons with the control or the 
impaired 2-tailed Student t test. The differences were 
considered significant for p values less than 0.05.
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Results
rDP2 reduced viability and induced apoptosis of BEAS‑2B 
cell
Effects of rDP2 on epithelial cell viability were investigated 
using MTT assay. As shown in Fig. 1a, 24 h-rDP2 treatments 
reduced cell viability of BEAS-2B in a dose-dependent man-
ner and the viability was decreased up to 79.4 ±  0.7 % of 
control in response to 40 μg/mL rDP2 (P < 0.005 as com-
pared to GST treatment). To confirm the rDP2-induced cell 
death, cell cycle distribution analysis was performed and the 
results revealed that rDP2 dose-dependently elevated sub-
G1 phase up to 22.4 ± 1.3 % (P < 0.005 as compared to GST 
treatment). In parallel, the GST treatment slightly increased 
sub-G1 phase to 7.2 ± 3.3 % (P = 0.273 as compared to neg-
ative control) (Fig.  1b). In addition, TUNEL assay showed 
that apoptotic cell ratio was increased to 24.1 ± 4.2 % of con-
trol in response to rDP2 treatment (40 μg/mL) (P < 0.005 as 
compared to GST treatment), and no TUNEL-positive cell 
was detected in the control and the GST treatment (Fig. 1c). 
PI/annexin V staining was also used for detection of apop-
totic cell. As shown in Fig. 1d, rDP2 significantly increased 
apoptotic cell ratio from 14.6 (5 μg/mL) to 20.4 % (20 μg/
mL) as compared to GST (9.2 %). These findings revealed 
that rDP2 triggered apoptotic cell death and consequently 
reduced the cell viability of BEAS-2B.
rDP2 induced increase of intracellular ROS and activation 
of intrinsic apoptosis cascades in BEAS‑2B cell
ROS is commonly assumed as an important stress factor 
involving in pathogenesis of allergic airway diseases and 
activation of mitochondrial pathway [13]. To investigate 
whether rDP2 induced ROS, intracellular ROS level was 
then determined. As shown in Fig.  2a, rDP2 increased 
level of intracellular ROS in a dose-dependent man-
ner and the intracellular ROS level was elevated up to 
208.6 ± 28.7 % of negative control in response to 40 μg/
mL rDP2 treatment (P < 0.01 as compared to GST treat-
ment) (Fig. 2a). In addition, level of cytosolic cytochrome 
c was significantly increased in BEAS-2B cells treated with 
rDP2. In parallel to increased cytosolic cytochrome c, our 
results showed that rDP2 triggered activation of caspase-9 
and the downstream effector caspase-3 (Fig. 2b). In con-
trast to rDP2, GST treatment neither significantly altered 
level of intracellular ROS and cytosolic cytochrome c nor 
triggered activation of caspase-9 in BEAS-2B cells (Fig. 2). 
Taken together, these findings showed that rDP2 elevated 
level of intracellular ROS, cytosolic cytochrome c and 
activation of mitochondrial pathway.
rDP2 triggered intrinsic apoptotic signaling in BEAS‑2B cell 
via activation of P38 and JNK
P38 and JNK have been reported to play important roles 
in mitochondrial pathway and ROS generation [14, 15]. 
Therefore, involvement of P38 and JNK activation in 
rDP2-triggered mitochondrial pathway was investigated. 
As shown in Fig.  3a, rDP2, but not GST, significantly 
induced phosphorylation of P38 and JNK. In addition, 
inhibition of P38 and JNK by specific inhibitor SB203580 
and SP600125 diminished the DP-induced cleavage 
of caspase-9, caspase-3 and PARP (Fig.  3b). In paral-
lel, levels of anti-apoptotic Bcl-2 and pro-apoptotic Bax 
and Bak were decreased and increased respectively in 
response to rDP2 (Fig. 3c). The increase of Bax and Bak 
by rDP2 was reversed by pretreatment of SB203580 and 
SP600125; however, the decrease of Bcl-2 by rDP2 was 
insignificantly affected by the inhibitors (Fig.  3c). These 
results revealed that rDP2 induced activation of P38 and 
JNK that involved in mitochondrial apoptotic signals in 
BEAS-2B cell in response to rDP2.
rDP2 promoted expression of Fas and FasL in BEAS‑2B cell 
through P38 and JNK activation
In addition to mitochondrial pathway, P38 and JNK have 
also been reported to associate with extrinsic pathway 
via regulating Fas and Fas ligand (FasL) expression [16]. 
Therefore, whether rDP2 affects expression of Fas and 
FasL is investigated. As shown in Fig. 4a, rDP2 increased 
protein level of FasL and Fas, and inhibition of P38 and 
JNK activation by SB203580 and SP600125 diminished 
the increase of Fas and FasL in BEAS-2B cell stimulated 
by rDP2. Similar results were also observed in mRNA 
expression of Fas and FasL determining by RT-PCR and 
qPCR, respectively (Fig.  4b, c). Collectively, these find-
ings showed that rDP2 upregulated both protein and 
mRNA expression of Fas and FasL in BEAS-2B cells via 
P38 and JNK activation.
rDP2 enhanced caspase‑8 activation via Akt/
GSK3β‑mediated down‑regulation of c‑FLIP in BEAS‑2B cell
GSK3β is regarded as an important mediator that con-
trols level of c-FLIP, a caspase-8 inhibitor [17]. Our 
previous study demonstrates that rDP2 inhibits GSK3β 
through Akt-mediated phosphorylation at serine 9 
in human lung carcinoma A549 cell [12]. Therefore, 
whether rDP2 induces phosphorylation of GSK3β (Ser9) 
and consequently alters level of c-FLIP in BEAS-2B cell 
is further investigated. As shown in Fig. 5a, phosphoryl-
ated GSK3β (Ser9), consistent with phosphorylated Akt 
(Ser478), was increased in BEAS-2B cells treated with 
rDP2, and the increase of phosphorylated GSK3β (Ser9) 
was significantly diminished by pretreatment of PI3K 
inhibitor wortmannin. Further results revealed that level 
of c-FLIP was dose-dependently decreased in BEAS-
2B cells in response to rDP2. In parallel to decrease of 
c-FILP level, cleaved caspase-8 level was significantly 
increased (Fig. 5b). Notably, the rDP2-induced decrease 
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of c-FLIP and increase of cleaved caspase-8 was restored 
by pretreatment of wortmannin. These results showed 
that rDP2 enhanced caspase-8 activation attributing 
to Akt/GSK3β-mediated down-regulation of c-FLIP in 
BEAS-2B cell.
Involvement of TLR2 signaling in DP2‑induced apoptosis 
of BEAS‑2B cell
Der p 2 is known to activate TLR2/MyD88/NF-κB signal-
ing and triggers inflammatory responses [18]. Thus, the 
role of TLR2 in Der p 2-induced apoptosis is investigated. 
As shown in Fig. 6, silencing TLR2 expression by specific 
siRNA decreased apoptotic cell ratio from 27.0 ± 2.7 % to 
14.1 ± 1.6 % in response to rDP2 treatments (P < 0.05). 
These findings showed that TLR2 signaling may partially 
involve in rDP2-induced apoptosis of BEAS-2B cells.
Discussion
Apoptosis is commonly observed in alveolar epithelial 
cells in pulmonary fibrosis, a condition that predisposes 
Fig. 1 rDP2 reduced cell viability and induced cellular apoptosis of BEAS‑2B cells. Cells were treated with rDP2 at indicated concentrations for 24 h, 
and then the cells were subjected to a cell viability assay, b cell cycle assay by flow cytometric analysis, c TUNEL assay, or d PI/annexin V staining 
with flow cytometric analysis. Three independent experiments were performed for statistical analysis. **p < 0.01 and ***p < 0.005 as compared to 
GST treatment (40 μg/mL, 24 h)
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to severe asthma [18]. Asthmatic bronchial epithelium 
is characteristically damaged with loss of columnar epi-
thelial cells that is highly relative to unregulated apopto-
sis [19]. The present study indicates that non-proteolytic 
aeroallergen rDP2 reduces viability of BEAS-2B cell 
via inducing apoptosis, suggesting that rDP2 not only 
evokes immune responses but also directly causes dam-
age of airway epithelium. Previous studies have indicated 
roles for ROS in the pathology of asthma both in terms 
of increased stress and decreased antioxidant protection 
[20]. In addition, airway responses have been shown to 
correlate with oxidant generation by eosinophils after 
antigen challenge in vivo [21] and neutrophil superoxide 
generation correlates with bronchial hyperreactivity [22]. 
Our results demonstrate that rDP2 promotes intracel-
lular ROS level, which may contribute to the increase of 
Bax/Bcl-2 ratio and the cytochrome c release in BEAS-
2B cell. These findings provide evidences that rDP2 may 
contributes to airway hyperreactivity via enhancing 
intracellular ROS and the consequent pathogenic and 
pro-apoptotic signaling in epithelial cells.
Cellular apoptosis is mediated by a fine balance of 
pro- and anti-apoptotic proteins in cells. Particularly, 
the mitochondrial apoptosis pathway is regulated by 
early translocation of anti-apoptotic (Bcl-2 and Bcl-XL) 
and pro-apoptotic (Bak and Bax) members of the Bcl-2 
family of proteins to or from mitochondria [23], which 
modulate the release of pro-apoptotic components such 
as cytochrome c that activate the apoptosome, effecter 
caspases and DNases resulting in DNA fragmentation 
and cleaved PARP. Furthermore, the presence of cleaved 
PARP (p85) has been reported as an important marker 
of early apoptosis in asthmatic bronchial epithelium 
[19]. Our results reveal that rDP2 decreases Bcl-2 but 
increases Bax and Bak level in BEAS-2B cells, as well as 
increases p85 PARP, indicating that rDP2 triggers intrin-
sic apoptosis of human bronchial epithelial cells attrib-
uting to imbalance of pro-apoptotic and anti-apoptotic 
members.
A recent study reports that Dermatophagoides pteron-
yssinus (DP) extract can inhibit apoptosis of human neu-
trophil [24]. The DP extract, generally, consists of more 
than ten types of allergens that have been identified and 
characterized [5]. Among the identified DP allergens, 
group 1 and group 3 is known to possess protease activ-
ity, and the others are non-proteolytic [5]. In this study, 
our findings indicate that rDP2 evokes apoptosis of epi-
thelial cell BEAS-2B. It suggests that the discrepancy may 
result from different cell types in response to multiple 
allergens and single allergen. However, it is interesting 
that mite allergens can prolong the neutrophil by inhib-
iting its apoptosis and meanwhile, induce the apopto-
sis of airway epithelial cell, which synergically enhances 
inflammatory response and airway remodeling that fur-
ther exacerbates the airway injury. Further investigation 
is needed to clarify the underlying mechanism.
MAPK signaling cascades were revealed in a myriad of 
fundamental cellular processes including proliferation, 
motility, stress reaction and apoptosis. Among MAPKs, 
JNK and P38 activation are generally pro-apoptotic in 
Fig. 2 rDP2 increased intracellular ROS and cytosolic cytochrome c and induced activation of caspase‑9 and caspase‑3 in BEAS‑2B cell. Cells were 
treated with rDP2 at indicated concentrations for 24 h, and then the cells were subjected to a intracellular ROS assay or b immunoblotting for 
indicated proteins. Three independent experiments were performed for statistical analysis. *p < 0.05 and **p < 0.01 as compared to GST treatment 
(40 μg/mL, 24 h). Signals of tubulin were used as internal control
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response to stress and cellular damage [25, 26]. JNK/
P38 activation has been reported to contribute to hyper-
phosphorylation of c-Jun and promote transcription of 
FasL, leading to apoptosis of ovarian carcinoma cell [27]. 
In addition, active P38 phosphorylates Bcl-xL and Bcl-2 
and prevents the accumulation of these anti-apoptotic 
Fig. 3 Involvement of P38 and JNK in activation of caspases and imbalance of pro‑apoptotic components in BEAS‑2B cell stimulated with rDP2. 
Cells were treated with rDP2 at indicated concentrations for 30 min (a) or pretreated with indicated inhibitors for 2 h and then with rDP2 at 
indicated concentrations 24 h (b, c), and then the cells were subjected to immunoblotting for indicated proteins. Signals of tubulin were used as 
internal control
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components within the mitochondria, contributing to 
loss of mitochondrial membrane potential and the release 
of cytochrome c [28]. P38 is also known to mediate Fas-
induced mitochondrial death pathway in CD8+  T cells 
[28]. Interestingly, our results reveal that rDP2 up-regu-
lates both mRNA expression and protein level of Fas and 
FasL via JNK and P38 activation, indicating that rDP2 
not only triggers intrinsic pathway but also reinforces 
Fig. 4 Involvement of P38 and JNK in rDP2‑mediated upregulation of Fas and FasL in BEAS‑2B cell. Cells were pretreated with or without indicated 
inhibitors, and then treated with rDP2 at indicated concentrations for 24 h (a) or 6 h (b, c). The treated cells were subjected to a immunoblotting, 
b RT‑PCR, or c qPCR for Fas and FasL expression, respectively. Signals of tubulin and GAPDH were used as internal control for immunoblotting and 
RT‑PCR, respectively. Three independent experiments were performed for statistical analysis. #p < 0.05 as compared to GST treatment. *p < 0.05 and 
**p < 0.01 as compared to 40 μg/mL rDP2 treatment
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extrinsic apoptosis via up-regulation of death-inducing 
receptor and its ligand through JNK/P38 pathway.
c-FLIP is a death effector domain (DED)-containing 
family member that inhibits one of the most proximal 
steps of death receptor (DR)-mediated apoptosis. After 
being recruited to the death-induced signaling complex 
(DISC), c-FLIP suppresses pro-caspase-8 activation and 
inhibits DR-mediated apoptosis via different mechanisms 
[29, 30]. A recent study demonstrates that a linkage 
between GSK3 inhibition and c-FLIP down-regulation, 
thus highlighting a new mechanism by which GSK3 
modulates the extrinsic apoptotic pathway [31]. Similar 
with the previous findings, the present study reveals that 
rDP2 inhibits GSK3β by Akt-mediated phosphorylation 
at serine-9, consequently down-regulating c-FLIP and 
enhancing extrinsic apoptotic pathway.
Der p 2 has been reported to induce inflammatory 
responses via activation of TLR2/4 and the downstream 
MyD88/NF-kB pathway [6, 7, 32]. The capability of TLR 
activation links Der p 2 to be regarded as an innate 
immunity activator. A very recent study shows that Der 
p 2 can be internalized by epithelial cell that promotes 
TLR-mediated proinflammatory signaling [33]. These 
findings demonstrates that TLRs play a crucial role in 
Der p 2-triggered cellular signaling and inflammatory 
responses. Similarly, our results indicates that TLR2 
partially involves in rDP2-induced epithelial apoptosis. 
However, the TLR2-independent apoptotic signaling in 
response to Der p 2 needs further investigation.
In summary, this study shows a novel mechanism by 
which rDP2 induces mitochondrial pathway and pro-
motes extrinsic pathway by up-regulation of Fas/FasL 
and down-regulation of c-FLIP through Akt-dependent 
phosphorylation of GSK3β (Ser9). Through this study, 
we are able to show, for the first time, that the non-pro-
teolytic aeroallergen rDP2 directly triggers apoptosis of 
Fig. 5 Involvement of Akt/GSK3β and c‑FLIP in activation of caspases‑8 in BEAS‑2B cell treated with rDP2. Cells were pretreated with or without 
wortmannin for 2 h, and then treated with rDP2 at indicated concentrations for 30 min. The treated cells were subjected to immunoblotting for a 
Akt/GSK3β phosphorylation, and b c‑FLIP/caspase‑8 cleavage. Signals of tubulin were used as internal control
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airway epithelial cell via both intrinsic and extrinsic path-
way and highlights the role of JNK/P38 and TLR2 signal-
ing in the rDP2-induced apoptosis, thus providing a new 
reasonable explanation for how rDP2 exacerbates airway 
damage in chronic respiratory diseases.
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